Neuroleptic malignant syndrome and serotonin syndrome

Laura M. Tormoehlen, Daniel Rusyniak

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. Clinical features, pathophysiology, and treatment strategies will be discussed, in addition to differentiating between these two syndromes and differentiating them from other hyperthermic or febrile syndromes. Our goal is to both review the current literature and to provide a practical guide to identification and treatment of these potentially life-threatening illnesses. The diagnostic and treatment recommendations made by us, and by other authors, are likely to change with a better understanding of the pathophysiology of these syndromes.

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages663-675
Number of pages13
DOIs
StatePublished - Jan 1 2018

Publication series

NameHandbook of Clinical Neurology
Volume157
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Fingerprint

Serotonin Syndrome
Neuroleptic Malignant Syndrome
Drug-Induced Abnormalities
Body Temperature Regulation
Pharmaceutical Preparations
Fever
Therapeutics

Keywords

  • bromocriptine
  • cyproheptadine
  • dantrolene
  • hyperthermia
  • malignant catatonia
  • neuroleptic malignant syndrome
  • serotonin syndrome

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Tormoehlen, L. M., & Rusyniak, D. (2018). Neuroleptic malignant syndrome and serotonin syndrome. In Handbook of Clinical Neurology (pp. 663-675). (Handbook of Clinical Neurology; Vol. 157). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-64074-1.00039-2

Neuroleptic malignant syndrome and serotonin syndrome. / Tormoehlen, Laura M.; Rusyniak, Daniel.

Handbook of Clinical Neurology. Elsevier B.V., 2018. p. 663-675 (Handbook of Clinical Neurology; Vol. 157).

Research output: Chapter in Book/Report/Conference proceedingChapter

Tormoehlen, LM & Rusyniak, D 2018, Neuroleptic malignant syndrome and serotonin syndrome. in Handbook of Clinical Neurology. Handbook of Clinical Neurology, vol. 157, Elsevier B.V., pp. 663-675. https://doi.org/10.1016/B978-0-444-64074-1.00039-2
Tormoehlen LM, Rusyniak D. Neuroleptic malignant syndrome and serotonin syndrome. In Handbook of Clinical Neurology. Elsevier B.V. 2018. p. 663-675. (Handbook of Clinical Neurology). https://doi.org/10.1016/B978-0-444-64074-1.00039-2
Tormoehlen, Laura M. ; Rusyniak, Daniel. / Neuroleptic malignant syndrome and serotonin syndrome. Handbook of Clinical Neurology. Elsevier B.V., 2018. pp. 663-675 (Handbook of Clinical Neurology).
@inbook{fa2e53d4c054451cae9f0706718f1316,
title = "Neuroleptic malignant syndrome and serotonin syndrome",
abstract = "The clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. Clinical features, pathophysiology, and treatment strategies will be discussed, in addition to differentiating between these two syndromes and differentiating them from other hyperthermic or febrile syndromes. Our goal is to both review the current literature and to provide a practical guide to identification and treatment of these potentially life-threatening illnesses. The diagnostic and treatment recommendations made by us, and by other authors, are likely to change with a better understanding of the pathophysiology of these syndromes.",
keywords = "bromocriptine, cyproheptadine, dantrolene, hyperthermia, malignant catatonia, neuroleptic malignant syndrome, serotonin syndrome",
author = "Tormoehlen, {Laura M.} and Daniel Rusyniak",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/B978-0-444-64074-1.00039-2",
language = "English (US)",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier B.V.",
pages = "663--675",
booktitle = "Handbook of Clinical Neurology",

}

TY - CHAP

T1 - Neuroleptic malignant syndrome and serotonin syndrome

AU - Tormoehlen, Laura M.

AU - Rusyniak, Daniel

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. Clinical features, pathophysiology, and treatment strategies will be discussed, in addition to differentiating between these two syndromes and differentiating them from other hyperthermic or febrile syndromes. Our goal is to both review the current literature and to provide a practical guide to identification and treatment of these potentially life-threatening illnesses. The diagnostic and treatment recommendations made by us, and by other authors, are likely to change with a better understanding of the pathophysiology of these syndromes.

AB - The clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. Clinical features, pathophysiology, and treatment strategies will be discussed, in addition to differentiating between these two syndromes and differentiating them from other hyperthermic or febrile syndromes. Our goal is to both review the current literature and to provide a practical guide to identification and treatment of these potentially life-threatening illnesses. The diagnostic and treatment recommendations made by us, and by other authors, are likely to change with a better understanding of the pathophysiology of these syndromes.

KW - bromocriptine

KW - cyproheptadine

KW - dantrolene

KW - hyperthermia

KW - malignant catatonia

KW - neuroleptic malignant syndrome

KW - serotonin syndrome

UR - http://www.scopus.com/inward/record.url?scp=85056743876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056743876&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-64074-1.00039-2

DO - 10.1016/B978-0-444-64074-1.00039-2

M3 - Chapter

C2 - 30459031

AN - SCOPUS:85056743876

T3 - Handbook of Clinical Neurology

SP - 663

EP - 675

BT - Handbook of Clinical Neurology

PB - Elsevier B.V.

ER -